Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$327M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$271M |
| 3 |
Chevron
CVX
|
+$264M |
| 4 |
JPMorgan Chase
JPM
|
+$233M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$396M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart Inc
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.73% |
| 2 | Technology | 14.98% |
| 3 | Financials | 10.9% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
VeriSign
VRSN
$23.9B
| $1.13B | 1.16% |
7,037,800
+122,700
| +2% | +$18.8M |
|
2
Align Technology
ALGN
$12.4B
| $1.09B | 1.12% |
2,778,381
-116,419
| -4% | -$43M |
|
3
Humana
HUM
$47.7B
| $1.07B | 1.1% |
3,174,800
+391,300
| +14% | +$127M |
|
4
Palo Alto Networks
PANW
$273B
| $1.05B | 1.08% |
27,907,200
+5,553,000
| +25% | +$202M |
|
5
Domino's
DPZ
$10.6B
| $939M | 0.96% |
3,183,800
-267,700
| -8% | -$75.8M |
|
|
NVO
6
Novo Nordisk
NVO
$213B
| $927M | 0.95% |
39,333,342
+1,048,742
| +3% | +$25.6M |
|
7
Amgen
AMGN
$198B
| $853M | 0.88% |
4,115,145
+311,545
| +8% | +$61.4M |
|
|
VMW
8
DELISTED
VMware, Inc
VMW
| $802M | 0.82% |
5,136,168
-153,632
| -3% | -$23.5M |
|
9
Vertex Pharmaceuticals
VRTX
$120B
| $788M | 0.81% |
4,089,117
+38,500
| +1% | +$6.86M |
|
|
ABMD
10
DELISTED
Abiomed Inc
ABMD
| $773M | 0.79% |
1,719,023
+167,600
| +11% | +$66.1M |
|
11
PepsiCo
PEP
$185B
| $740M | 0.76% |
6,620,250
-342,600
| -5% | -$38.8M |
|
12
Progressive
PGR
$119B
| $605M | 0.62% |
8,511,700
+1,416,800
| +20% | +$91.1M |
|
13
Crown Castle
CCI
$33.8B
| $602M | 0.62% |
5,405,300
+115,597
| +2% | +$12.9M |
|
14
NVIDIA
NVDA
$5.14T
| $588M | 0.6% |
83,658,600
+24,066,880
| +40% | +$157M |
|
15
Bristol-Myers Squibb
BMY
$124B
| $580M | 0.6% |
9,344,000
-1,203,200
| -11% | -$71.4M |
|
16
Molina Healthcare
MOH
$11.6B
| $556M | 0.57% |
3,738,755
+932,905
| +33% | +$119M |
|
17
BP
BP
$112B
| $550M | 0.57% |
12,486,038
+2,862,723
| +30% | +$120M |
|
18
Meta Platforms (Facebook)
META
$1.59T
| $548M | 0.56% |
3,332,556
+865,068
| +35% | +$157M |
|
19
Duke Energy
DUK
$99.7B
| $484M | 0.5% |
6,051,129
+1,980,562
| +49% | +$160M |
|
20
Dell
DELL
$285B
| $483M | 0.5% |
17,725,684
-2,049,218
| -10% | -$54.7M |
|
21
FirstEnergy
FE
$28.5B
| $458M | 0.47% |
12,312,308
+304,900
| +3% | +$11.1M |
|
|
AZPN
22
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $456M | 0.47% |
4,002,003
+139,203
| +4% | +$15.9M |
|
23
Idexx Laboratories
IDXX
$43B
| $444M | 0.46% |
1,778,004
-391,925
| -18% | -$95.1M |
|
24
Colgate-Palmolive
CL
$73.3B
| $444M | 0.46% |
6,627,800
-573,100
| -8% | -$38.2M |
|
25
Cboe Global Markets
CBOE
$29.5B
| $439M | 0.45% |
4,570,700
-619,500
| -12% | -$62.5M |
|
Similar funds
Renaissance Technologies's Q3 2018 Portfolio in Review
As of Q3 2018, Renaissance Technologies held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Renaissance Technologies's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
- Renaissance Technologies added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
- Renaissance Technologies's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
- Renaissance Technologies fully exited Apple in Q3 2018, selling an estimated $707M.
- Renaissance Technologies's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
- Renaissance Technologies opened 508 new positions and closed 410 in Q3 2018.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $97.3B.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.